Shandong Xinhua Pharmaceutical Company Limited announced that Mr. Ling Peixue("Mr. Ling") has tendered his resignation as an independent non-executive director of the Company and has ceased to be a member of each of the Strategic Development Committee and Remuneration and Examination Committee of the Board, and all positions in the subsidiaries of the Company, all with effect from 26 July 2023 in order to devote more time to handle other matters. Following the resignation of Mr. Ling, he no longer holds any position in the Company. The Board will appoint a new independent non-executive director as soon as possible in accordance with the Articles of Association and the relevant provisions. Upon the resignation of Mr. Ling, the number of the members of the Strategic Development Committee is still 4, and the number of the members of the Remuneration and Examination
Committee of the Company is still 3, the Company is considering suitable candidates to fill the above vacancies as soon as possible.